These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 29405076)
21. Special endpoint and product specific considerations in pharmaceutical acceptable daily exposure derivation. Gould J; Callis CM; Dolan DG; Stanard B; Weideman PA Regul Toxicol Pharmacol; 2016 Aug; 79 Suppl 1():S79-93. PubMed ID: 27233924 [TBL] [Abstract][Full Text] [Related]
22. Pre-clinical methods for detecting the hypersensitivity potential of pharmaceuticals: regulatory considerations. Hastings KL Toxicology; 2001 Feb; 158(1-2):85-9. PubMed ID: 11164997 [TBL] [Abstract][Full Text] [Related]
23. Role of animal models in the study of drug-induced hypersensitivity reactions. Uetrecht J AAPS J; 2006 Jan; 7(4):E914-21. PubMed ID: 16594644 [TBL] [Abstract][Full Text] [Related]
24. Towards better models and mechanistic biomarkers for drug-induced gastrointestinal injury. Carr DF; Ayehunie S; Davies A; Duckworth CA; French S; Hall N; Hussain S; Mellor HR; Norris A; Park BK; Penrose A; Pritchard DM; Probert CS; Ramaiah S; Sadler C; Schmitt M; Shaw A; Sidaway JE; Vries RG; Wagoner M; Pirmohamed M Pharmacol Ther; 2017 Apr; 172():181-194. PubMed ID: 28132905 [TBL] [Abstract][Full Text] [Related]
25. [Diagnostics of drug hypersensitivity reactions]. Möbs C; Pfützner W Hautarzt; 2017 Jan; 68(1):19-28. PubMed ID: 28005146 [TBL] [Abstract][Full Text] [Related]
26. An Update on the Immunological, Metabolic and Genetic Mechanisms in Drug Hypersensitivity Reactions. Mayorga C; Montañez MI; Jurado-Escobar R; Gil-Ocaña V; Cornejo-García JA Curr Pharm Des; 2019; 25(36):3813-3828. PubMed ID: 31692430 [TBL] [Abstract][Full Text] [Related]
27. Human biology-based drug safety evaluation: scientific rationale, current status and future challenges. Kenna JG Expert Opin Drug Metab Toxicol; 2017 May; 13(5):567-574. PubMed ID: 28150517 [TBL] [Abstract][Full Text] [Related]
28. Advances in the development and use of human tissue-based techniques for drug toxicity testing. Clotworthy M; Archibald K Expert Opin Drug Metab Toxicol; 2013 Sep; 9(9):1155-69. PubMed ID: 23687950 [TBL] [Abstract][Full Text] [Related]
29. The role of reactive drug metabolites in immune-mediated adverse drug reactions. Hess DA; Rieder MJ Ann Pharmacother; 1997 Nov; 31(11):1378-87. PubMed ID: 9391694 [TBL] [Abstract][Full Text] [Related]
30. The use of T cells in hazard characterization of chemical and drug allergens and integration in testing strategies. Foreword. Kimber I; Pallardy M Exp Suppl; 2014; 104():1-7. PubMed ID: 24214614 [No Abstract] [Full Text] [Related]
31. Contribution of new technologies to characterization and prediction of adverse effects. Rouquié D; Heneweer M; Botham J; Ketelslegers H; Markell L; Pfister T; Steiling W; Strauss V; Hennes C Crit Rev Toxicol; 2015 Feb; 45(2):172-83. PubMed ID: 25615431 [TBL] [Abstract][Full Text] [Related]
32. Pro and Contra: Provocation Tests in Drug Hypersensitivity. Soyer O; Sahiner UM; Sekerel BE Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28677662 [TBL] [Abstract][Full Text] [Related]
33. Role of bioactivation in drug-induced hypersensitivity reactions. Sanderson JP; Naisbitt DJ; Park BK AAPS J; 2006 Feb; 8(1):E55-64. PubMed ID: 16584134 [TBL] [Abstract][Full Text] [Related]
34. Drug allergies--unknown dangers to patients. Demoly P Expert Opin Drug Saf; 2008 Jul; 7(4):347-50. PubMed ID: 18613799 [TBL] [Abstract][Full Text] [Related]
35. Assessing drug safety in human tissues - what are the barriers? Holmes A; Bonner F; Jones D Nat Rev Drug Discov; 2015 Aug; 14(8):585-7. PubMed ID: 26205467 [No Abstract] [Full Text] [Related]
36. Allergic hepatitis induced by drugs. Castell JV; Castell M Curr Opin Allergy Clin Immunol; 2006 Aug; 6(4):258-65. PubMed ID: 16825865 [TBL] [Abstract][Full Text] [Related]
37. Patch testing for adverse drug reactions. Sekhon S; Nedorost ST Cutis; 2017 Jan; 99(1):49-54. PubMed ID: 28207004 [TBL] [Abstract][Full Text] [Related]